BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Pancreatic cancer AND ELN, ENSG00000049540, 2006, WS, WBS, SVAS, FLJ43523, FLJ38671 AND Diagnosis
266 results:

  • 1. The impact of vascular margin invasion on local recurrence after pancreatoduodenectomy in pancreatic adenocarcinoma.
    López JC; Ielpo B; Iglesias M; Pinilla FB; Sánchez-Velázquez P
    Langenbecks Arch Surg; 2024 Apr; 409(1):122. PubMed ID: 38607450
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Microbial profile in bile from pancreatic and extra-pancreatic biliary tract cancer.
    Di Carlo P; Serra N; Fasciana TMA; Giammanco A; D'Arpa F; Rea T; Napolitano MS; Lucchesi A; Cascio A; Sergi CM
    PLoS One; 2024; 19(2):e0294049. PubMed ID: 38381746
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. The role of insulinoma-associated protein 1 in predicting the progression and prognosis of human olfactory neuroblastoma in China.
    Yang Y; Yue C; Li Y; Piao Y
    Pathol Res Pract; 2024 Jan; 253():155040. PubMed ID: 38171083
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Trends in treatment patterns and survival outcomes in pancreatic cancer: A nationwide population-based study in Korea.
    Park BK; Seo JH; Han JH; Lee KJ; Son KJ; Choi JK
    Eur J Cancer; 2023 Aug; 189():112932. PubMed ID: 37352643
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Clinical features and images of malignant lymphoma localized in the pancreatic head to differentiate from pancreatic ductal adenocarcinoma: a case series study.
    Kato N; Yamaguchi A; Sugata S; Hamada T; Furuya N; Mizumoto T; Tamaru Y; Kusunoki R; Kuwai T; Kouno H; Tazuma S; Sudo T; Kido M; Ito T; Kuraoka K; Kohno H
    BMC Gastroenterol; 2023 May; 23(1):138. PubMed ID: 37127562
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Clinical Practice Guidelines for pancreatic cancer 2022 from the Japan Pancreas Society: a synopsis.
    Okusaka T; Nakamura M; Yoshida M; Kitano M; Ito Y; Mizuno N; Hanada K; Ozaka M; Morizane C; Takeyama Y;
    Int J Clin Oncol; 2023 Apr; 28(4):493-511. PubMed ID: 36920680
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Disparities in primary pancreatic adenocarcinoma survival by Medicaid-status: A national population-based risk analysis.
    Ganga A; Kim EJ; Mintzer GL; Adriance W; Wang R; Cholankeril G; Balkrishnan R; Somasundar PS
    Eur J Surg Oncol; 2023 Jul; 49(7):1242-1249. PubMed ID: 36801151
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Limitations and prospects in the management of IPMN: a retrospective, single-center observational study.
    Peisl S; Burckhardt O; Egger B
    BMC Surg; 2023 Jan; 23(1):3. PubMed ID: 36611137
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Disparities in Receipt of Adjuvant Therapy After Upfront Surgical Resection for pancreatic Ductal Adenocarcinoma.
    Anteby R; Blaszkowsky LS; Hong TS; Qadan M
    Ann Surg Oncol; 2023 Apr; 30(4):2473-2481. PubMed ID: 36585536
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. The Clinicopathologic Characteristics and Outcomes of Gastroentero-pancreatic Neuroendocrine Tumors - Experience from A Tertiary cancer Center.
    Ali J; Rahat A; Shah MH; Sajjad M; Malik I; Ikram SI; Ul Qamar MF
    Gulf J Oncolog; 2022 Sep; 1(40):7-14. PubMed ID: 36448065
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Recent trends in the incidence and survival of stage I liver cancer: a surveillance, epidemiology, and end results analysis.
    Yu XC; Liu JB; Tang QH; Diao X; Fan QY; Huang ZY; Tang XM; Li S; Cao YF; Ma YS; Fu D
    Ann Med; 2022 Dec; 54(1):2785-2795. PubMed ID: 36370068
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Risk of nonalcoholic fatty liver disease and associations with gastrointestinal cancers.
    McHenry S; Zong X; Shi M; Fritz CDL; Pedersen KS; Peterson LR; Lee JK; Fields RC; Davidson NO; Cao Y
    Hepatol Commun; 2022 Dec; 6(12):3299-3310. PubMed ID: 36221229
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Evolving knowledge in surgical oncology of pancreatic cancer: from theory to clinical practice-a fifteen-year journey at a tertiary referral centre.
    Casadei R; Ricci C; Ingaldi C; Alberici L; De Raffele E; Barcia B; Mosconi C; Diegoli M; Di Marco M; Brandi G; Zagari RM; Pagano N; Eusebi LH; Serra C; Migliori M; Guido A; Santini D; Rosini F; Malvi D; Minni F
    Updates Surg; 2022 Oct; 74(5):1533-1542. PubMed ID: 36008632
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Measured weight loss as a precursor to cancer diagnosis: retrospective cohort analysis of 43 302 primary care patients.
    Nicholson BD; Thompson MJ; Hobbs FDR; Nguyen M; McLellan J; Green B; Chubak J; Oke JL
    J Cachexia Sarcopenia Muscle; 2022 Oct; 13(5):2492-2503. PubMed ID: 35903866
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Identification of patients with branch-duct intraductal papillary mucinous neoplasm and very low risk of cancer: multicentre study.
    Tamburrino D; de Pretis N; Pérez-Cuadrado-Robles E; Uribarri-Gonzalez L; Ateeb Z; Belfiori G; Maisonneuve P; Capurso G; Vanella G; Petrone MC; Arcidiacono PG; Vaalavuo Y; Frulloni L; Dominguez-Muñoz JE; Deprez PH; Falconi M; Del Chiaro M; Crippa S; Laukkarinen J
    Br J Surg; 2022 Jun; 109(7):617-622. PubMed ID: 35511697
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Systematic review and meta-analysis of MRI features for differentiating autoimmune pancreatitis from pancreatic adenocarcinoma.
    Yoon SB; Jeon TY; Moon SH; Lee SM; Kim MH
    Eur Radiol; 2022 Oct; 32(10):6691-6701. PubMed ID: 35486167
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Association of Pathogenic Variants in Hereditary cancer Genes With Multiple Diseases.
    Zeng C; Bastarache LA; Tao R; Venner E; Hebbring S; Andujar JD; Bland ST; Crosslin DR; Pratap S; Cooley A; Pacheco JA; Christensen KD; Perez E; Zawatsky CLB; Witkowski L; Zouk H; Weng C; Leppig KA; Sleiman PMA; Hakonarson H; Williams MS; Luo Y; Jarvik GP; Green RC; Chung WK; Gharavi AG; Lennon NJ; Rehm HL; Gibbs RA; Peterson JF; Roden DM; Wiesner GL; Denny JC
    JAMA Oncol; 2022 Jun; 8(6):835-844. PubMed ID: 35446370
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Validation of the Enriching New-Onset Diabetes for pancreatic cancer Model: A Retrospective Cohort Study Using Real-World Data.
    Boursi B; Patalon T; Webb M; Margalit O; Beller T; Yang YX; Chodick G
    Pancreas; 2022 Feb; 51(2):196-199. PubMed ID: 35404897
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. SEROUS CYSTADENOMA OF PANCREAS: WHY THERE IS LOW ACCURACY IN IMAGING EXAMS?
    Amico EC; Salgado CTS; Emerenciano LM; Ferreira Filho GAS; Alves JR; Souza LEOFF; Silva JSPD
    Arq Bras Cir Dig; 2022; 34(4):e1640. PubMed ID: 35107502
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Trends in diagnosis and Treatment of Metastatic cancer in the United States.
    Lehrer EJ; Stoltzfus KC; Jones BM; Gusani NJ; Walter V; Wang M; Trifiletti DM; Siva S; Louie AV; Zaorsky NG
    Am J Clin Oncol; 2021 Nov; 44(11):572-579. PubMed ID: 34560720
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 14.